| Patient | Marie Curie |
|---|---|
| Date of birth | 1959-11-07 |
| Identifiers | MRN HR-ET013-SYN; SSN (made up) 000-13-2758 |
| Document date | 2026-11-01 |
| Author | Adaeze Nwosu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for two months of fatigue, breathlessness on stairs, easy bruising, and a recent fever. Concerns: Exhausted and short of breath for two months, with bruises she cannot explain; Wonders whether her years of radiation work caused this, and wants her laboratory staff protected; Blurred, glary vision in the right eye is slowing her reading. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cyclosporine (modified) 100 mg oral capsule, one capsule twice daily, dose adjusted to trough levels by hematology | One capsule by mouth twice daily; hematology adjusts the dose to trough levels | Oral route | 2026-05-18 | active | S |
| Eltrombopag 75 mg oral tablet, two tablets (150 mg) once daily on an empty stomach | Two tablets by mouth once daily, two hours before or four hours after food, dairy, or antacids | Oral route | 2026-05-18 | active | S |
| Acyclovir 400 mg oral tablet, one tablet twice daily during immunosuppression | One tablet by mouth twice daily | Oral route | 2026-05-18 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Transfusion of two units of irradiated, leukocyte-depleted red cells for symptomatic anemia | 2026-05-11 to 2026-05-11 | completed | S |
| Bone marrow aspirate and trephine biopsy: about 10% cellularity with no dysplasia, fibrosis, or malignant cells; cytogenetics normal; no PNH clone | 2026-05-18 to 2026-05-18 | completed | S |
| Comprehensive eye examination: best-corrected acuity 20/60 right and 20/30 left; posterior capsule opacification in the right eye; normal intraocular pressure; no retinal hemorrhages | 2026-06-15 to 2026-06-15 | completed | S |
| YAG laser posterior capsulotomy, right eye | 2026-06-22 to 2026-06-22 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2025-10-20 | Influenza vaccine, 2025-2026 season | completed | S |
| 2025-10-20 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 2019-03-12 | Tdap vaccine | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1920 to 1930 | Double cataract diagnosed in 1920, with severe visual impairment; four operations between 1923 and 1930 restored enough vision for laboratory work and driving | D (CLM-0004, CLM-0005) |
| Interpretation of the 1920 diagnosis | Cataracts interpreted retrospectively as radiation cataract | R (CLM-0006) |
| Before 1929 | Severe burns of the fingers from handling radioactive materials with bare hands | D (CLM-0007) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Tuberculosis; died in May 1878 at age 42 after a five-year illness | D (CLM-0011) | |
| sister | Typhus, caught from a boarder; the eldest sister died when Marie was eight | D (CLM-0011) |
| Concern | Status | Evidence |
|---|---|---|
| Exhausted and short of breath for two months, with bruises she cannot explain | active | S |
| Wonders whether her years of radiation work caused this, and wants her laboratory staff protected | active | S |
| Blurred, glary vision in the right eye is slowing her reading | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 8.9 on 2026-06-29; Leukocytes [#/volume] in Blood by Automated count 2.4 on 2026-06-29; Neutrophils [#/volume] in Blood by Automated count 0.8 on 2026-06-29; Platelets [#/volume] in Blood by Automated count 34 on 2026-06-29; MCV [Entitic mean volume] in Red Blood Cells by Automated count 101 on 2026-06-29; Reticulocytes [#/volume] in Blood by Automated count 31 on 2026-06-29; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 512 on 2026-05-11; Folate [Mass/volume] in Serum or Plasma 14.2 on 2026-05-11; Ferritin [Mass/volume] in Serum or Plasma 185 on 2026-05-11; Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma 180 on 2026-05-11; Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 on 2026-05-11; Sodium [Moles/volume] in Serum or Plasma 138 on 2026-06-29; Potassium [Moles/volume] in Serum or Plasma 4.9 on 2026-06-29; Creatinine [Mass/volume] in Serum or Plasma 1.02 on 2026-06-29; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 61 on 2026-06-29; Glucose [Mass/volume] in Serum or Plasma 98 on 2026-06-29; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 on 2026-06-29; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 on 2026-06-29 [S]
Strengths and supports: Supports: two adult daughters, one also a scientist, and a sister who is a physician [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Severe aplastic anemia: pancytopenia with a low reticulocyte count, confirmed by a hypocellular bone marrow; attributed to cumulative occupational ionizing radiation; linked to the documented 1934 diagnosis | active | confirmed | D61.2 | S — Synthetic modern diagnosis; the 1934 report remains D and the radiation cause is R. |
| Occupational exposure to ionizing radiation over decades of radium research and X-ray work | active | confirmed | Z57.1 | S — Synthetic modern coding of the documented exposure history. |
| Posterior capsule opacification, right eye, after earlier bilateral cataract surgery; glare and blurred reading vision | active | confirmed | H26.491 | S — Synthetic eye finding linked to the documented cataracts and operations. |
| Chronic radiodermatitis of the fingertips, with thin, scarred skin | active | confirmed | L58.1 | S — Synthetic skin finding linked to the documented finger burns. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-11 | Hemoglobin [Mass/volume] in Blood | 7.2 | g/dL | 11.6-15 g/dL | Low | S |
| 2026-05-11 | Leukocytes [#/volume] in Blood by Automated count | 1.9 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 2026-05-11 | Neutrophils [#/volume] in Blood by Automated count | 0.4 | 10*3/uL | 1.5-7.5 10*3/uL | Low | S |
| 2026-05-11 | Platelets [#/volume] in Blood by Automated count | 18 | 10*3/uL | 150-400 10*3/uL | Low | S |
| 2026-05-11 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 104 | fL | 80-100 fL | High | S |
| 2026-05-11 | Reticulocytes [#/volume] in Blood by Automated count | 14 | 10*3/uL | 25-100 10*3/uL | Low | S |
| 2026-05-11 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 512 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-05-11 | Folate [Mass/volume] in Serum or Plasma | 14.2 | ng/mL | >=5.9 ng/mL | Normal | S |
| 2026-05-11 | Ferritin [Mass/volume] in Serum or Plasma | 185 | ng/mL | 15-150 ng/mL | High | S |
| 2026-05-11 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 180 | U/L | 125-220 U/L | Normal | S |
| 2026-05-11 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-05-11 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-05-11 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-05-11 | Creatinine [Mass/volume] in Serum or Plasma | 0.78 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-05-11 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 84 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-05-11 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-05-11 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-05-18 | Hemoglobin [Mass/volume] in Blood | 8.9 | g/dL | 11.6-15 g/dL | Low | S |
| 2026-05-18 | Leukocytes [#/volume] in Blood by Automated count | 1.8 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 2026-05-18 | Neutrophils [#/volume] in Blood by Automated count | 0.4 | 10*3/uL | 1.5-7.5 10*3/uL | Low | S |
| 2026-05-18 | Platelets [#/volume] in Blood by Automated count | 15 | 10*3/uL | 150-400 10*3/uL | Low | S |
| 2026-05-18 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 101 | fL | 80-100 fL | High | S |
| 2026-05-18 | Reticulocytes [#/volume] in Blood by Automated count | 12 | 10*3/uL | 25-100 10*3/uL | Low | S |
| 2026-06-08 | Hemoglobin [Mass/volume] in Blood | 8.2 | g/dL | 11.6-15 g/dL | Low | S |
| 2026-06-08 | Leukocytes [#/volume] in Blood by Automated count | 2 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 2026-06-08 | Neutrophils [#/volume] in Blood by Automated count | 0.5 | 10*3/uL | 1.5-7.5 10*3/uL | Low | S |
| 2026-06-08 | Platelets [#/volume] in Blood by Automated count | 21 | 10*3/uL | 150-400 10*3/uL | Low | S |
| 2026-06-08 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 102 | fL | 80-100 fL | High | S |
| 2026-06-08 | Reticulocytes [#/volume] in Blood by Automated count | 18 | 10*3/uL | 25-100 10*3/uL | Low | S |
| 2026-06-08 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 | U/L | 7-35 U/L | Normal | S |
| 2026-06-08 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-06-08 | Potassium [Moles/volume] in Serum or Plasma | 4.8 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-06-08 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-06-08 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 65 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-06-08 | Glucose [Mass/volume] in Serum or Plasma | 101 | mg/dL | 70-99 mg/dL | High | S |
| 2026-06-29 | Hemoglobin [Mass/volume] in Blood | 8.9 | g/dL | 11.6-15 g/dL | Low | S |
| 2026-06-29 | Leukocytes [#/volume] in Blood by Automated count | 2.4 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 2026-06-29 | Neutrophils [#/volume] in Blood by Automated count | 0.8 | 10*3/uL | 1.5-7.5 10*3/uL | Low | S |
| 2026-06-29 | Platelets [#/volume] in Blood by Automated count | 34 | 10*3/uL | 150-400 10*3/uL | Low | S |
| 2026-06-29 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 101 | fL | 80-100 fL | High | S |
| 2026-06-29 | Reticulocytes [#/volume] in Blood by Automated count | 31 | 10*3/uL | 25-100 10*3/uL | Normal | S |
| 2026-06-29 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 | U/L | 7-35 U/L | Normal | S |
| 2026-06-29 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-06-29 | Potassium [Moles/volume] in Serum or Plasma | 4.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-06-29 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-06-29 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 61 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-06-29 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-06-29 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 2 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-11 | Body height | 157 | cm | S |
| 2026-05-11 | Body weight | 51 | kg | S |
| 2026-05-11 | Body mass index (BMI) [Ratio] | 20.7 | kg/m2 | S |
| 2026-05-11 | Systolic blood pressure | 112 | mm[Hg] | S |
| 2026-05-11 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-05-11 | Heart rate | 104 | /min | S |
| 2026-05-11 | Respiratory rate | 18 | /min | S |
| 2026-05-11 | Body temperature | 37.4 | Cel | S |
| 2026-05-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-05-18 | Body height | 157 | cm | S |
| 2026-05-18 | Body weight | 51 | kg | S |
| 2026-05-18 | Body mass index (BMI) [Ratio] | 20.7 | kg/m2 | S |
| 2026-05-18 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-05-18 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-05-18 | Heart rate | 92 | /min | S |
| 2026-05-18 | Respiratory rate | 16 | /min | S |
| 2026-05-18 | Body temperature | 36.9 | Cel | S |
| 2026-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-06-08 | Body height | 157 | cm | S |
| 2026-06-08 | Body weight | 51.5 | kg | S |
| 2026-06-08 | Body mass index (BMI) [Ratio] | 20.9 | kg/m2 | S |
| 2026-06-08 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-06-08 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-06-08 | Heart rate | 90 | /min | S |
| 2026-06-08 | Respiratory rate | 16 | /min | S |
| 2026-06-08 | Body temperature | 36.8 | Cel | S |
| 2026-06-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-06-29 | Body height | 157 | cm | S |
| 2026-06-29 | Body weight | 52 | kg | S |
| 2026-06-29 | Body mass index (BMI) [Ratio] | 21.1 | kg/m2 | S |
| 2026-06-29 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-06-29 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-06-29 | Heart rate | 86 | /min | S |
| 2026-06-29 | Respiratory rate | 16 | /min | S |
| 2026-06-29 | Body temperature | 36.7 | Cel | S |
| 2026-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-05-11 | Primary care visit for two months of fatigue, breathlessness on stairs, easy bruising, and a recent fever | finished | S |
| 2026-05-18 | Hematology consultation with bone marrow aspirate and biopsy for pancytopenia | finished | S |
| 2026-06-08 | Primary care follow-up three weeks after starting immunosuppressive therapy, with a cataract and eye review | finished | S |
| 2026-06-29 | Primary care follow-up six weeks into immunosuppressive therapy, after laser capsulotomy of the right eye | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Urgent hematology referral for pancytopenia with a low reticulocyte count, for bone marrow aspirate and biopsy, cytogenetics, and PNH testing | completed | GL-BSH-AA-2024 | S |
| Initial anemia workup in primary care: CBC with differential and reticulocyte count, blood film, vitamin B12, folate, ferritin, LDH, bilirubin, and kidney function | completed | GL-CMID-2026, GL-BSH-AA-2024 | S |
| Supportive care: irradiated, leukocyte-depleted red cells for symptomatic anemia; platelet thresholds set by hematology; same-day assessment for a temperature of 38 °C or higher; avoid aspirin and NSAIDs | completed | GL-BSH-AA-2024 | S |
| Record cumulative occupational radiation exposure, stop further exposure while counts recover, and review shielding and dosimetry for laboratory staff with occupational health | completed | GL-BSH-AA-2024 | S |
| First-line immunosuppressive therapy given by hematology: horse antithymocyte globulin with cyclosporine and eltrombopag, plus acyclovir prophylaxis; inactivated vaccines only | completed | GL-BSH-AA-2024 | S |
| Monitor CBC weekly during the first months of treatment, with kidney function, potassium, and ALT every two weeks on cyclosporine and eltrombopag | completed | GL-BSH-AA-2024, GL-CMID-2026 | S |
| Comprehensive dilated eye examination with best-corrected acuity, intraocular pressure, slit-lamp examination, and a functional vision assessment; YAG laser capsulotomy when capsule opacification limits daily tasks; eye examinations every one to two years afterward | completed | GL-AAO-CAT-2021, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Hematology evaluation with bone marrow biopsy within one week of the pancytopenia result | 2026-05-18 | completed | Seen and biopsied seven days after the first visit | S |
| No serious infection or bleeding during the first months of treatment | 2026-06-29 | completed | No infection or bleeding through the sixth week of therapy | S |
| Early rise in neutrophil and platelet counts by the six-week visit | 2026-06-29 | completed | Neutrophils rose from 0.4 to 0.8 and platelets from 18 to 34 thousand per microliter; formal response is judged at three to six months | S |
| Read standard print comfortably with the right eye after capsulotomy | 2026-06-29 | completed | Reading without glare one week after laser capsulotomy | S |